2021 annual financial data
Syndax Pharmaceuticals 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 20.85%.
Operating income was 26,220,000 USD and net income was 24,926,000 USD.
Operating cash flow was 29,131,000 USD.
Get free Syndax Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 139,709,000 USD
- Operating income
- 26,220,000 USD
- Net income
- 24,926,000 USD
- Operating cash flow
- 29,131,000 USD